ATE551353T1 - Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten - Google Patents
Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthaltenInfo
- Publication number
- ATE551353T1 ATE551353T1 AT04725350T AT04725350T ATE551353T1 AT E551353 T1 ATE551353 T1 AT E551353T1 AT 04725350 T AT04725350 T AT 04725350T AT 04725350 T AT04725350 T AT 04725350T AT E551353 T1 ATE551353 T1 AT E551353T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- syncitin
- fusogenic
- activity similar
- sequence
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000000799 fusogenic effect Effects 0.000 title abstract 3
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45997403P | 2003-04-04 | 2003-04-04 | |
| PCT/EP2004/003552 WO2004087748A1 (en) | 2003-04-04 | 2004-04-02 | Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE551353T1 true ATE551353T1 (de) | 2012-04-15 |
Family
ID=33131908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04725350T ATE551353T1 (de) | 2003-04-04 | 2004-04-02 | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1651667B1 (de) |
| AT (1) | ATE551353T1 (de) |
| WO (1) | WO2004087748A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE538802T1 (de) | 2005-03-30 | 2012-01-15 | Viroxis | Endogener retrovirus und proteine, kodiert durch env-gen, als target für die krebsbehandlung |
| EP3356389A1 (de) * | 2015-10-01 | 2018-08-08 | Aimvion A/S | Verwendung von menschlichen immunsuppressiven proteinen und peptiden als arzneimittel |
| EP3235828A1 (de) * | 2016-04-21 | 2017-10-25 | Genethon | Stabile pseudotypisierte lentivirale teilchen und verwendungen davon |
| WO2018037042A1 (en) * | 2016-08-23 | 2018-03-01 | Aimvion A/S | Novel immunostimulating peptides |
| KR102761577B1 (ko) | 2017-05-08 | 2025-02-03 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 막 융합을 촉진시키기 위한 조성물 및 그의 용도 |
| WO2019077150A1 (en) * | 2017-10-20 | 2019-04-25 | Genethon | USE OF SYNCYTIN TO TARGET A MEDICINAL PRODUCT AND GENE ADMINISTRATION TO PULMONARY TISSUE |
| CN111246874A (zh) * | 2017-10-20 | 2020-06-05 | 吉尼松公司 | 合胞素用于将药物和基因靶向递送至再生肌肉组织的用途 |
| EP3852813A4 (de) | 2018-09-18 | 2022-06-22 | VNV Newco Inc. | Lichtbogenbasierte kapside und deren verwendungen |
| US11129892B1 (en) | 2020-05-18 | 2021-09-28 | Vnv Newco Inc. | Vaccine compositions comprising endogenous Gag polypeptides |
| EP4486763A1 (de) * | 2022-03-04 | 2025-01-08 | Institut Pasteur | Aufnahmemechanismus von essentiellen lysophospholipiden ins gehirn und hemmung durch endogenes retrovirales hüllprotein |
| CN118561966A (zh) * | 2024-05-20 | 2024-08-30 | 浙江大学 | 人内源性逆转录病毒包膜蛋白突变体、截短体及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2797889A1 (fr) | 1999-09-01 | 2001-03-02 | Bio Merieux | Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AU2002255478A1 (en) * | 2001-01-10 | 2002-09-12 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
| US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
-
2004
- 2004-04-02 EP EP04725350A patent/EP1651667B1/de not_active Expired - Lifetime
- 2004-04-02 AT AT04725350T patent/ATE551353T1/de active
- 2004-04-02 WO PCT/EP2004/003552 patent/WO2004087748A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP1651667B1 (de) | 2012-03-28 |
| EP1651667A1 (de) | 2006-05-03 |
| WO2004087748A1 (en) | 2004-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| PT1548032E (pt) | Péptidos kdr e vacinas que os contêm | |
| IL175319A0 (en) | Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof | |
| AR047347A1 (es) | Miembros de la familia cry9 de bacillus | |
| MX2009004147A (es) | Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1. | |
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| MX2010002001A (es) | Peptido cdca1 y agente farmaceutico que comprende elmismo. | |
| ATE551353T1 (de) | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten | |
| DK1904529T3 (da) | Anvendelse af Stefin A som et scaffoldprotein | |
| WO2021248016A3 (en) | Novel omni-59, 61, 67, 76, 79, 80, 81, and 82 crispr nucleases | |
| DE60335726D1 (de) | Chromoprotein und fluoroproteine | |
| BR112022012057A2 (pt) | Novos métodos de entrega celular | |
| AU4653301A (en) | Anti-freeze proteins, their production and use | |
| MX2011004176A (es) | Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo. | |
| MX2024004272A (es) | Nueva proteina de polen de junipero. | |
| HK1147210A1 (en) | Anti-hypertensive agent | |
| WO2018200814A3 (en) | Modified cyclic peptides and therapeutic use thereof | |
| MX2023007406A (es) | Composiciones que comprenden ciclotidos y otros peptidos insecticidas y usos de las mismas. | |
| MY182816A (en) | Cancer antigen peptide | |
| ATE286535T1 (de) | Regulatorisches protein pke 83 aus humanen keratinozyten |